Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.fiercebiotech.com/biotech/jj-sees-deal-opportunities-neuroscience-and-immunology-post-ambrx-buy
https://www.cnbc.com/2024/01/08/jj-to-acquire-ambrx-biopharma-a-cancer-drug-developer.html
https://www.globenewswire.com//news-release/2024/01/08/2805344/0/en/Ambrx-Announces-Sale-to-Johnson-Johnson.html
https://www.globenewswire.com//news-release/2023/10/23/2764675/0/en/Ambrx-Announces-ARX517-a-PSMA-Targeted-ADC-Demonstrates-a-Promising-52-PSA50-50-Reduction-and-a-Highly-Differentiated-Safety-and-PK-Profile-in-Patients-with-mCRPC-who-Progressed-on.html
https://www.fiercebiotech.com/biotech/esmo-ambrxs-reset-arrives-last-line-prostate-cancer-offering-not-one-serious-adverse-event
https://seekingalpha.com/news/4021400-ambrx-biopharma-files-300m-mixed-securities-shelf
https://www.globenewswire.com//news-release/2023/10/16/2760559/0/en/Ambrx-Provides-Safety-and-Efficacy-Data-from-Ongoing-Phase-1-2-APEX-01-Trial-of-ARX517-in-mCRPC-at-ESMO-Congress.html
https://ir.ambrx.com/news/news-details/2023/ESMO-2023-Abstracts-Available-Here/default.aspx
https://www.globenewswire.com//news-release/2023/09/26/2749516/0/en/Ambrx-to-Host-KOL-Event-Discussing-ARX517-Data-Presented-at-ESMO-Congress-2023.html